New Oral Cancer Diagnostic

by Larry Emmott on June 12, 2006

in Diagnostics,General

Vel1LED Dental Inc., has been granted FDA clearance to market its Visually Enhanced Lesion Scope – or VELscope

The VELscope system consists of a light source and direct viewing handpiece that will be used during oral cancer and mucosal screenings as part of routine dental hygiene visits on all adult patients. Specifically, VELscope is an adjunctive screening device that utilizes a narrow band of high-energy blue light and specialized filter technology to help evaluate oral mucosa for abnormal areas of concern, such as potentially cancerous lesions that can be undetectable under white light.

“We are extremely pleased that the FDA has made such a swift determination on VELscope – a device that we firmly believe will help dentists, hygienists and other oral healthcare providers save countless lives by identifying oral mucosal abnormalities that are or may lead to oral cancer,” said LED Dental Inc. president, Wayne Rees.

See the web site here

by: at .

Share

Comments on this entry are closed.

Previous post:

Next post: